Sebby Borriello, VP and chief commercial officer of SK Life Science, details his company’s experience launching Xcopri, an epilepsy drug, during the COVID-19 crisis.
Novo Nordisk adapts Rybelsus launch to the coronavirus era
The FDA said drug and device reviews are continuing at the normal rate, but warned that may not be able to continue indefinitely as the pandemic drags on.
Splice Agency on the differences between East and West Coast biopharma
A half-day event at Splice headquarters in San Francisco focused on the differences between East and West Coast biopharma, both in culture and how they approach customers.
AI Deciphered: Discovering the Potential for Marketers and Communicators